New research reveals factors that control the interplay of natural killer (NK) cells—which are part of the body's innate, or first line, immune response—with tumor cells, viral infections, and solid organ transplants. ...
Mar 16, 2022
0
121
New research led by Dr. John Maher, from the School of Cancer & Pharmaceutical Sciences, working for Leucid Bio and with biotech company LUMICKS, has been published in the February 2022 issue of Frontiers in Immunology.
Mar 8, 2022
0
7
T cells play important roles in helping to fight infections and cancers—and they can also drive autoimmune diseases. Now researchers at La Jolla Institute for Immunology (LJI) have discovered new genes in CD4+ "helper" ...
Feb 25, 2022
0
422
University of Otago researchers have discovered a new function for the hormone prolactin—it limits a new mom's investment in aggressive behavior and instead focuses them on interacting with their babies.
Feb 21, 2022
0
164
Cancerous tumors are made up of rapidly growing, abnormally shaped, cells that can infiltrate and destroy healthy tissues, travel to other parts of the body, and form additional tumors. In part because of its rapid and invasive ...
Feb 7, 2022
0
36
A new study by researchers at Yale Cancer Center shows inhibition of the CECR2 gene prevents triple-negative breast cancer from advancing or metastasizing. The discovery is an early step in finding new therapeutics for triple-negative ...
Feb 3, 2022
0
137
Biomedical engineers at Duke University have developed a method to study how key cells in the kidneys become injured and deformed. The new model has revealed a significant mechanism behind severe kidney disease and pointed ...
Jan 26, 2022
0
44
Researchers from The Australian National University (ANU) have identified why certain cells in the body, known as Th17 cells, go rogue and promote the onset of autoimmune diseases such as multiple sclerosis (MS).
Jan 26, 2022
0
188
Chinese scientists recently reported the key role in tumor survival played by a histone-acetylation-regulated long noncoding RNA called lysosome cell death regulator (LCDR), providing a potential diagnostic and therapeutic ...
Jan 17, 2022
0
8
Multiple myeloma is a cancer of the bone marrow, with a life expectancy of less than 5 years post-diagnosis. Proteasome inhibitors, the therapeutic backbone of current treatments, are very effective in treating newly diagnosed ...
Jan 12, 2022
0
18
